88 related articles for article (PubMed ID: 1492596)
21. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
23. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.
Hebbar M; Révillion F; Louchez MM; Vilain MO; Fournier C; Bonneterre J; Peyrat JP
Clin Cancer Res; 1998 Feb; 4(2):373-80. PubMed ID: 9516925
[TBL] [Abstract][Full Text] [Related]
24. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
[TBL] [Abstract][Full Text] [Related]
25. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Jirsa M; Tesar V
Cas Lek Cesk; 1998 May; 137(11):341-5. PubMed ID: 9727208
[TBL] [Abstract][Full Text] [Related]
26. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
[TBL] [Abstract][Full Text] [Related]
27. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
28. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of tumor necrosis factor (TNF) in cancer patients].
Volod'ko NA; Bulinskiĭ BT; Kidar OV
Vopr Onkol; 1994; 40(4-6):181-5. PubMed ID: 7785241
[TBL] [Abstract][Full Text] [Related]
31. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
Aderka D; Englemann H; Hornik V; Skornick Y; Levo Y; Wallach D; Kushtai G
Cancer Res; 1991 Oct; 51(20):5602-7. PubMed ID: 1655258
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of erythrosedimentation rate in cancer in relation to cytokine production: correlation with high IL-6 and low IL-2 blood concentrations.
Lissoni P; Brivio F; Pittalis S; Rovelli F; Rescaldani R; Perego MS; Grassi MG; Barni S; Tancini G; Majorca F; Fumagalli L
J Biol Regul Homeost Agents; 1996; 10(2-3):60-2. PubMed ID: 9250887
[TBL] [Abstract][Full Text] [Related]
33. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
[TBL] [Abstract][Full Text] [Related]
34. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
36. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer.
Mokart D; Capo C; Blache JL; Delpero JR; Houvenaeghel G; Martin C; Mege JL
Br J Surg; 2002 Nov; 89(11):1450-6. PubMed ID: 12390391
[TBL] [Abstract][Full Text] [Related]
37. Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretion.
Lissoni P; Rovelli F; Giani L; Fumagalli L; Meregalli S; Comi G; Merlini D
J Biol Regul Homeost Agents; 1996; 10(4):92-4. PubMed ID: 9604777
[TBL] [Abstract][Full Text] [Related]
38. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
39. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
40. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
Jabłońska E; Kiluk M; Markiewicz W; Piotrowski L; Grabowska Z; Jabłoński J
Arch Immunol Ther Exp (Warsz); 2001; 49(1):63-9. PubMed ID: 11266093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]